Welcome to the Oncomine Blog
-
Biomarker Tests for Precision Oncology: DIY or Pay-for-Service?
Cancer patient management of is increasingly driven by biomarker assays – but how should we manage t... -
The Impact of NGS in Hematology-Oncology
In aggressive forms of cancer such as acute myeloid leukemia (AML), accurate diagnosis is needed as ... -
The OncomineWorld Experience from Behind the Curtain
BACKGROUND: There is little to no point in saying that we are all living in an unprecedented time, b... -
Comprehensive Biomarker Testing Reveals RET Alteration to Change Course of NSCLC Patient’s Treatment Options and Survival Outcome
It’s been a tough road for Melissa Crouse, sometimes almost deadly. She had a lobe of her left lung ... -
Building a Case for In-House Next Generation Sequencing
Diagnostics lab team demonstrates how insourcing NGS makes sound financial sense and helps deliver c... -
Shifting the Paradigm: Broader Patient Access to Personalized Oncology Treatments Hinges on In-House Comprehensive Genomic Testing
We are living in an unprecedented time in the collective fight against cancer, where recent developm... -
The Importance of Detecting the Most Fusions Across the Most Patients
In recent years, we’ve seen an increasing number of new therapies emerge that target gene fusions in...